IRIS
ORA, JOSUEL
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.452
AS - Asia 2.552
EU - Europa 1.681
SA - Sud America 380
Continente sconosciuto - Info sul continente non disponibili 299
AF - Africa 37
OC - Oceania 11
Totale 18.412
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.327
SG - Singapore 1.224
IT - Italia 462
CN - Cina 425
BR - Brasile 298
HK - Hong Kong 295
RU - Federazione Russa 248
VN - Vietnam 199
IE - Irlanda 160
FR - Francia 149
DE - Germania 142
PL - Polonia 121
UA - Ucraina 114
GB - Regno Unito 93
BD - Bangladesh 91
KR - Corea 90
JP - Giappone 63
CA - Canada 61
FI - Finlandia 49
IN - India 38
NL - Olanda 37
SE - Svezia 31
MX - Messico 27
ID - Indonesia 26
AR - Argentina 22
ES - Italia 16
VE - Venezuela 16
AT - Austria 15
EC - Ecuador 14
TR - Turchia 14
AU - Australia 11
BE - Belgio 11
CR - Costa Rica 11
IQ - Iraq 11
ZA - Sudafrica 11
CO - Colombia 10
PH - Filippine 10
JM - Giamaica 9
SA - Arabia Saudita 8
CL - Cile 7
MY - Malesia 7
PK - Pakistan 7
AE - Emirati Arabi Uniti 6
EG - Egitto 6
PT - Portogallo 6
PY - Paraguay 6
UZ - Uzbekistan 6
IR - Iran 5
LT - Lituania 5
PE - Perù 5
TW - Taiwan 5
JO - Giordania 4
KE - Kenya 4
KW - Kuwait 4
NG - Nigeria 4
BG - Bulgaria 3
CI - Costa d'Avorio 3
DZ - Algeria 3
EU - Europa 3
GR - Grecia 3
MA - Marocco 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
AZ - Azerbaigian 2
BH - Bahrain 2
BS - Bahamas 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
EE - Estonia 2
HN - Honduras 2
IL - Israele 2
LB - Libano 2
PR - Porto Rico 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BZ - Belize 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GT - Guatemala 1
HU - Ungheria 1
KG - Kirghizistan 1
KY - Cayman, isole 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 18.118
Salva come PNG Salva come JPEG
Città #
Wilmington 2.855
Woodbridge 2.777
Houston 2.697
Singapore 570
Ashburn 483
Fairfield 465
San Jose 437
Hong Kong 287
Chandler 218
Ann Arbor 216
Seattle 207
Council Bluffs 202
Cambridge 146
Dublin 140
Beijing 136
Santa Clara 122
New York 119
Medford 110
Kraków 104
Rome 102
Monte Vista 95
Los Angeles 91
Dallas 82
The Dalles 74
Dearborn 71
Ho Chi Minh City 68
Jacksonville 63
Tokyo 58
Lauterbourg 52
Lawrence 50
Hanoi 48
Moscow 44
Milan 42
Buffalo 40
Chicago 37
San Diego 34
São Paulo 31
Zhengzhou 28
Naples 25
Atlanta 24
Phoenix 24
San Francisco 24
Denver 23
Brooklyn 20
Chaozhou 20
Toronto 19
Montreal 18
Colorado Springs 17
Guangzhou 17
North Bergen 17
Redondo Beach 17
Jakarta 16
Orem 16
Nuremberg 15
Warsaw 15
Chennai 14
Rio de Janeiro 14
Salt Lake City 14
Frankfurt am Main 13
Helsinki 13
London 13
Miami 13
Lappeenranta 12
Verona 11
Belo Horizonte 10
Munich 10
Norwalk 10
Palo Alto 10
Washington 10
Menlo Park 9
San José 9
Bari 8
Boston 8
Brussels 8
Hefei 8
Johannesburg 8
Mexico City 8
Shenzhen 8
Caracas 7
Charlotte 7
Columbus 7
Da Nang 7
Detroit 7
Hải Dương 7
Kingston 7
Norwich 7
Poplar 7
Redwood City 7
Seoul 7
Amsterdam 6
Brasília 6
Elk Grove Village 6
Guayaquil 6
Haiphong 6
Kunming 6
Las Vegas 6
Philadelphia 6
Porto Alegre 6
Quito 6
Steuben 6
Totale 14.112
Salva come PNG Salva come JPEG
Nome #
Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells 523
A 6MWT index to predict O2 flow correcting exercise induced SpO2 desaturation in ILD 513
Optimizing drug delivery in COPD: The role of inhaler devices 500
Can an increased cholinergic tone constitute a predictor of positive response to tiotropium in patients with moderate asthma? 498
Effect of an additional dose of indacaterol in COPD patients under regular treatment with indacaterol. 496
Searching for the synergistic effect between aclidinium and formoterol: From bench to bedside 494
Onset of action of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in patients with COPD 492
Airflow obstruction: Is it asthma or is it COPD? 491
LABA/LAMA combination in copd: A meta-analysis on the duration of treatment 490
Impact of LABA/LAMA combination on exercise endurance and lung hyperinflation in COPD: A pair-wise and network meta-analysis 472
Treatment options for moderate-to-very severe chronic obstructive pulmonary disease 454
Role of muscarinic antagonists in asthma therapy 452
Effect of indacaterol on arterial blood gases in patients suffering from acute exacerbation of COPD 444
The Time Course of Pulmonary Function Tests in COPD Patients with Different Levels of Blood Eosinophils 442
An overview of the current management of chronic obstructive pulmonary disease: can we go beyond the GOLD recommendations? 442
Asthma management in a specialist setting: Results of an Italian Respiratory Society survey 440
Dog allergen immunotherapy and allergy to furry animals 434
Effect of adding roflumilast or ciclesonide to glycopyrronium on lung volumes and exercise tolerance in patients with severe COPD: A pilot study 431
Pharmacological assessment of the onset of action of aclidinium and glycopyrronium versus tiotropium in COPD patients and human isolated bronchi 430
Adherence to COPD treatment: Myth and reality 426
Olodaterol + tiotropium bromide for the treatment of chronic obstructive pulmonary disease 400
Gastroesophageal reflux and COPD exacerbations: Is cholinergic-mediated oesophago-bronchial reflex a possible link? 396
Pleiotropic effects of hypoglycemic agents: implications in asthma and COPD 380
Cardiopulmonary exercise test in athletes and coronary diseases|Test cardiopolmonare da sforzo negli atleti e nelle patologie coronariche 375
Dual bronchodilation and exacerbations of COPD 370
Canakinumab for the treatment of chronic obstructive pulmonary disease 355
The safety of dual bronchodilation on cardiovascular serious adverse events in COPD 309
The future of inhalation therapy in chronic obstructive pulmonary disease 291
The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: A quantitative synthesis 287
β-Blockers and Asthma: Surprising findings from the FAERS database 250
Current pharmacotherapeutic options for pediatric lower respiratory tract infections with a focus on antimicrobial agents 250
Inhaled therapies and cardiovascular risk in patients with chronic obstructive pulmonary disease 240
Efficacy and safety profile of doxofylline compared to theophylline in asthma: A meta-analysis 225
Depressive and anxiety symptoms in patients with SARS-CoV2 infection 223
Management of acute respiratory failure in interstitial lung diseases: Overview and clinical insights 217
Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection 196
Validation of “Clinical Red Flags” for RA-ILD in an Italian cohort 183
Comparing the Efficacy and Safety Profile of Triple Fixed-Dose Combinations in COPD: A Meta-Analysis and IBiS Score 179
Evolving Concepts in Chronic Obstructive Pulmonary Disease Blood-Based Biomarkers 174
Does bronchoscopy help the diagnosis in COVID-19 infection? 155
Advances with glucocorticoids in the treatment of asthma: state of the art 137
Dyspnea perception and neurological symptoms in non-severe COVID-19 patients 135
SMART and as-needed therapies in mild-to-severe asthma: a network meta-analysis 130
Pharmacokinetic/pharmacodynamic approaches to drug delivery design for inhalation drugs 129
Alteration of telomere length and mtDNA copy number in interstitial lung disease associated with rheumatoid arthritis 124
Clinically Important Deterioration (CID) and Ageing in COPD: A Systematic Review and Meta-Regression Analysis According to PRISMA Statement 116
The BNT162b2 mRNA COVID-19 vaccine increases the contractile sensitivity to histamine and parasympathetic activation in a human ex vivo model of severe eosinophilic asthma 113
An overview of the safety and efficacy of monoclonal antibodies for the chronic obstructive pulmonary disease 109
Long-acting muscarinic antagonists under investigational to treat chronic obstructive pulmonary disease 107
A clinician’s guide to single vs multiple inhaler therapy for COPD 105
Use of Thiols in the Treatment of COVID-19: Current Evidence 102
Exercise-Induced Asthma: Managing Respiratory Issues in Athletes 101
Real-World Efficacy of Biological Therapies in Severe Asthma: A Focus on Small Airways 100
Hyperglycaemia and Chronic Obstructive Pulmonary Disease 100
New avenues for phosphodiesterase inhibitors in asthma 100
Studio real-life sui pazienti con asma grave in terapia biologica: focus sulla funzionalità respiratoria 99
Acute effect of oxygen therapy on exercise tolerance and dyspnea perception in ILD patients 99
Treatable Mechanisms in Asthma 97
Guidance on nebulization during the current COVID-19 pandemic 94
Efficacy of respiratory tele-rehabilitation in COPD patients: Systematic review and meta-analysis 93
Sex differences in COPD management 92
Investigational anti IL-13 asthma treatments: a 2023 update 89
Strength of association between comorbidities and asthma: a meta-analysis 89
Step-up and step-down approaches in the treatment of asthma 89
Indacaterol/Glycopyrronium Combination for COPD 88
Management of COPD patients during COVID: difficulties and experiences 86
Happy hypoxemia, or blunted ventilation? 84
Current long-acting muscarinic antagonists for the treatment of asthma 84
Cardiovascular diseases or type 2 diabetes mellitus and chronic airway diseases: mutual pharmacological interferences 83
Pulmonary Rehabilitation in Noncystic Fibrosis Bronchiectasis 82
Effects of SARS-CoV-2 Infection on Pulmonary Function Tests and Exercise Tolerance 77
Ceiling effect of beclomethasone/formoterol/glycopyrronium triple fixed-dose combination in COPD: a translational bench-to-bedside study 75
Synergy across the drugs approved for the treatment of asthma 67
Biologic therapies for chronic obstructive pulmonary disease 67
Assessing the relationship between cardiovascular and small airway disease and acute events in COPD: The ARCADIA study protocol 66
Effects of SARS-CoV-2 on Pulmonary Function and Muscle Strength Testing in Military Subjects According to the Period of Infection: Cross-Sectional Study 65
Clinical challenges in applying the new lung function test interpretive strategies: navigating pitfalls and possible solutions 64
Expert guidance on the management and challenges of long-COVID syndrome: a systematic review 56
Totale 18.412
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.160
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.160
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022452 0 0 0 12 7 37 119 18 23 58 48 130
2022/2023594 102 44 24 60 54 138 48 34 49 7 18 16
2023/2024276 48 7 31 9 18 55 5 45 5 9 4 40
2024/20251.966 49 397 184 78 60 70 152 133 161 249 231 202
2025/20263.545 240 258 288 270 348 99 414 360 438 234 398 198
2026/20271.122 277 172 482 191 0 0 0 0 0 0 0 0
Totale 18.412